Oui Therapeutics, Inc.
9
2
2
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
11.1%
1 terminated/withdrawn out of 9 trials
75.0%
-11.5% vs industry average
0%
0 trials in Phase 3/4
67%
2 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Determining the Potential for Efficacy of OTX-601 in Reducing PTSD Symptoms
Role: lead
Pilot Trial of Mobile Technology for Adolescent Suicidality
Role: lead
Feasibility of a Digital Therapeutic for Adults With Posttraumatic Stress Disorder (PTSD)
Role: lead
A Study to Evaluate the Safety and Effectiveness of a Digital Therapeutic
Role: lead
A Self-Guided Mobile Intervention for Adults With Binge Eating and Obesity
Role: collaborator
A Feasibility Open Trial of App-Enhanced Brief CBT for Suicidal Inpatients
Role: collaborator
Feasibility of a Digital Therapeutic for Adults With Binge Eating and Obesity
Role: lead
Mobile Technology for Reducing and Preventing Adolescent Suicide
Role: collaborator
Feasibility Study of a Software Application for Patients Hospitalized After Suicidal Ideation or Suicide Attempts
Role: lead
All 9 trials loaded